WADDILL WILLIAM D. sold 70.1% of their position (12K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $979.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/14/2025ACC: 0001104659-25-099252
Director
Since Jun 2019
-12K
Net shares
Net seller
$979.5K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
12K acquired · 24K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+12K
Price / share
$6.98
Trade value
$83.76K
% of position
233.9%
10/10/2025
5.13K→17.13K
Common Stock
Direct
Shares
−4K
Price / share
$69.25
Trade value
$277K
% of position
23.4%
10/10/2025
17.13K→13.13K
Common Stock
Direct
Shares
−8K
Price / share
$87.81
Trade value
$702.48K
% of position
60.9%
10/10/2025
13.13K→5.13K
Total
Net shares
+0.00
Net value
-$895.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2025 | M · Option Exercise | +12K | $6.98 | $83.76K | 233.9% | 5.13K | 17.13K |
| Common Stock Direct | 10/10/2025 | S · Sale | −4K | $69.25 | $277K | 23.4% | 17.13K | 13.13K |
| Common Stock Direct | 10/10/2025 | S · Sale | −8K | $87.81 | $702.48K | 60.9% | 13.13K | 5.13K |
| Total | +0.00 | -$895.72K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
12K shares
Shares
−12K
Strike price
6.98
Held after
0.00
Exercisable
—
10/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock12K shares | 10/10/2025 | M · Option Exercise | −12K | 6.98 | — | 0.00 |